Mediar will receive a combined $99m consisting of an upfront payment and near-term milestones.
Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment
January 13, 2025
You may also like
Indices by TradingView
2 Undervalued AI Stocks to Buy in 2026 and Hold for Decades
January 20, 2026
Stocks slide after Trump threatens European allies with tariffs
January 20, 2026
Fmr. Netflix Exec Reacts to 4Q Results, Content Strategy
January 20, 2026
Categories
Indices by TradingView




